Open: 12:29 PM
BioAtla Stock Price Graph
BioAtla Stock Price Today
BioAtla, Inc. (BCAB) stock rallied over 2.58% intraday to trade at $1.59 a share on NASDAQ. The stock opened with a loss of -12.26% at $1.36 and touched an intraday high of $1.42, rising 2.58% against the last close of $1.55. The BioAtla, Inc. in stock market went to a low of $1.24 during the session.
BioAtla Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BioAtla Stock Price History Chart
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
Frequently Asked Questions
What is the current BioAtla, Inc. (BCAB) stock price?
BioAtla, Inc. (NASDAQ: BCAB) stock price is $1.59 in the last trading session. During the trading session, BCAB stock reached the peak price of $1.42 while $1.24 was the lowest point it dropped to. The percentage change in BCAB stock occurred in the recent session was 2.58% while the dollar amount for the price change in BCAB stock was $0.04.
BCAB's industry and sector of operation?
The NASDAQ listed BCAB is part of Biotechnology industry that operates in the broader Healthcare sector. BioAtla, Inc. , a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
Who are the executives of BCAB?
Mr. Christian Vasquez
Vice President of Fin., Corporation Controller & Sec.
Dr. Jay M. Short Ph.D.
Co-Founder, Chief Executive Officer & Chairman
Ms. Susie Melody
Senior Vice President of HR
Dr. Cathy Chang Ph.D.
Senior Vice President of R&D
How BCAB did perform over past 52-week?
BCAB's closing price is 0.81% higher than its 52-week low of $1.24 where as its distance from 52-week high of $11.73 is -0.70%.
How many employees does BCAB have?
Number of BCAB employees currently stands at N/A. BCAB operates from 11085 Torreyana Road, San Diego, CA 92121, US.
Link for BCAB official website?
Official Website of BCAB is: https://www.bioatla.com
How do I contact BCAB?
How many shares of BCAB are traded daily?
BCAB stock volume for the day was 272407.00 shares. The average number of BCAB shares traded daily for last 3 months was 407.52 Thousands.
What is the market cap of BCAB currently?
The market value of BCAB currently stands at $76 Million with its latest stock price at $1.59 and N/A of its shares outstanding.